Email updates

Keep up to date with the latest news and content from Nutrition & Metabolism and BioMed Central.

Open Access Research

Differential regulation of PGC-1α expression in rat liver and skeletal muscle in response to voluntary running

Renata Matiello1, Rosa T Fukui1, Maria ER Silva1, Dalva M Rocha1, Bernardo L Wajchenberg1, Salman Azhar2* and Rosa F Santos1*

Author Affiliations

1 Laboratory of Medical Investigation, LIM-18, Division of Endocrinology and Metabolism, Hospital of Clinics, School of Medicine, University of Sao Paulo. Av Dr Arnaldo, 455, 3rd floor, room 3324, Sao Paulo, 01246-903, Brazil

2 Geriatric Research, Educational and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California, 94304, USA and Stanford University, Stanford, California, 94305, USA

For all author emails, please log on.

Nutrition & Metabolism 2010, 7:36  doi:10.1186/1743-7075-7-36

The electronic version of this article is the complete one and can be found online at: http://www.nutritionandmetabolism.com/content/7/1/36


Received:18 February 2010
Accepted:30 April 2010
Published:30 April 2010

© 2010 Matiello et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

The beneficial actions of exercise training on lipid, glucose and energy metabolism and insulin sensitivity appear to be in part mediated by PGC-1α. Previous studies have shown that spontaneously exercised rats show at rest enhanced responsiveness to exogenous insulin, lower plasma insulin levels and increased skeletal muscle insulin sensitivity. This study was initiated to examine the functional interaction between exercise-induced modulation of skeletal muscle and liver PGC-1α protein expression, whole body insulin sensitivity, and circulating FFA levels as a measure of whole body fatty acid (lipid) metabolism.

Methods

Two groups of male Wistar rats (2 Mo of age, 188.82 ± 2.77 g BW) were used in this study. One group consisted of control rats placed in standard laboratory cages. Exercising rats were housed individually in cages equipped with running wheels and allowed to run at their own pace for 5 weeks. At the end of exercise training, insulin sensitivity was evaluated by comparing steady-state plasma glucose (SSPG) concentrations at constant plasma insulin levels attained during the continuous infusion of glucose and insulin to each experimental group. Subsequently, soleus and plantaris muscle and liver samples were collected and quantified for PGC-1α protein expression by Western blotting. Collected blood samples were analyzed for glucose, insulin and FFA concentrations.

Results

Rats housed in the exercise wheel cages demonstrated almost linear increases in running activity with advancing time reaching to maximum value around 4 weeks. On an average, the rats ran a mean (Mean ± SE) of 4.102 ± 0.747 km/day and consumed significantly more food as compared to sedentary controls (P < 0.001) in order to meet their increased caloric requirement. Mean plasma insulin (P < 0.001) and FFA (P < 0.006) concentrations were lower in the exercise-trained rats as compared to sedentary controls. Mean steady state plasma insulin (SSPI) and glucose (SSPG) concentrations were not significantly different in sedentary control rats as compared to exercise-trained animals. Plantaris PGC-1α protein expression increased significantly from a 1.11 ± 0.12 in the sedentary rats to 1.74 ± 0.09 in exercising rats (P < 0.001). However, exercise had no effect on PGC-1α protein content in either soleus muscle or liver tissue. These results indicate that exercise training selectively up regulates the PGC-1α protein expression in high-oxidative fast skeletal muscle type such as plantaris muscle.

Conclusion

These data suggest that PGC-1α most likely plays a restricted role in exercise-mediated improvements in insulin resistance (sensitivity) and lowering of circulating FFA levels.

Background

Insulin resistance, which reflects an impaired response of glucose transport to insulin, is an early characteristic in the development of type 2 diabetes [1,2]. Together with hyperinsulinemia, insulin resistance contributes to development of a cluster of interdependent metabolic abnormalities [3-6] that in aggregate increase the risk of cardiovascular disease by about 2-fold and raise the risk for type 2 diabetes by approximately 5-fold [5]. These metabolic abnormalities have been referred to by a variety of names in the past [4], but are now commonly called 'metabolic syndrome' [4-6]. The dramatic increase in the prevalence of obesity that reflects overnutrition, global adaptation of the Western type of diet along with increased consumption of refined sugars (fructose), and sedentary lifestyles, has led to a marked increase in metabolic syndrome and type 2 diabetes [4,7-12]. Insulin resistance is now considered a direct consequence of obesity-associated exposure of tissues to elevated dietary nutrients, resulting in accumulation of toxic metabolic by-products including lipid metabolites in insulin-sensitive tissues, such as the liver, skeletal muscle, and fat that become insulin resistant [13-17]. Extensive evidence now also points to a strong association between hepatic and skeletal muscle insulin resistance and dysregulation of whole body glucose homeostasis and fasting hyperglycemia in type-2 diabetes [13-15,17]. The insulin sensitizing drugs such as thiazolidinediones and metformin that specifically target insulin resistance are currently in use to treat type-2 diabetes, but other treatment regimens, namely dietary modifications and exercise, are also strongly advocated globally to alleviate the symptoms of type-2 diabetes. Indeed use of aerobic exercise regimen as an adjuvant therapy results in significant improvement in both insulin resistance and insulin action in major insulin-sensitive tissues [16,18-20]. While a number of molecular/biochemical mechanisms have been put forward to account for the exercise-induced attenuation of hepatic/skeletal muscle insulin resistance and enhanced insulin sensitivity, the underlying mechanism is still not well defined.

Peroxisome proliferator-activated receptor (PPAR)-γ coactivator (PGC)-1α is a highly inducible transcriptional coactivator that controls the transcription of genes involved in a wide variety of biological programs including adaptive thermogenesis, glucose and fatty acid metabolism, oxidative phosphorylation, mitochondrial biogenesis, fiber type switching in skeletal muscle and heart development [21-24]. Under normal and fed conditions, PGC-1α expression is relatively low in liver as compared to tissues such as heart, skeletal muscle, and brown adipose that rely on aerobic metabolism for ATP production [21,22,25]. Its expression in the liver is robustly induced in response to acute food deprivation, insulin resistance or diabetes [25-28], but reduced in obesity [29]. Both loss-of-function and gain-of-function studies have shown that PGC-1α differentially impacts the lipid/glucose metabolism and insulin sensitivity in liver and skeletal muscle. For example PGC-1α overexpression results in hepatic insulin resistance, manifested by higher glucose production and diminished insulin suppression of gluconeogenesis [30]. In contrast, PGC-1α overexpression leads to improved muscle insulin sensitivity, mitochondrial function and insulin regulated glucose metabolism [30-32]. PGC-1α deficiency on the other hand, is accompanied by alterations in energy metabolism in multiple tissues, muscle dysfunstion, hepatic lipid metabolism and insulin signaling and diminished hepatic gluconeogenesis [32-35]. When considered together, these various findings indicate that PGC-1α plays a central role in the regulation of metabolic pathways that control hepatic and skeletal muscle energy metabolism, lipid and glucose homeostasis and insulin action.

Recent studies have shown that exercise increases the expression of PGC-1α in skeletal muscle and it has been suggested that exercise-induced improvements in skeletal muscle oxidative metabolism and insulin sensitivity results, at least in part, through the activation and upregulation of PGC-1α [36-40]. However, it is not clear whether exercise-induced improvements in insulin regulated hepatic lipid and glucose metabolism is also linked to the modulation of PGC-1α expression in the liver. Furthermore, it is not clear whether or not activation and upregulation of PGC-1α occurs uniformly in all skeletal muscle types or restricted to certain fiber types. To address these questions, we have utilized a Wistar rat model of endurance training. The data presented here indicate that exercise selectively upregulates the protein expression of PGC-1α in high-oxidative fast (plantaris) skeletal muscle type. No changes in the PGC-1α protein expression, however, were noted in either the liver or a representative of slow oxidative (soleus) skeletal muscle type. These latter results raised the possibility that exercise-induced improvements that occur in hepatic lipid and glucose metabolism and insulin sensitivity are not fully dependent on the activation and participation of PGC-1α.

Methods

Animals

All experimental protocols were approved by the Ethics Committee for Review of Research Projects, of the Hospital of Clinics of the School of Medicine of the University of Sao Paulo. Male Wistar rats, (188.82 ± 2.77 g; 5 wk of age) were obtained from USP (Sao Paulo, Brazil) and kept in an environmentally controlled room (22 ± 1°C) with a 12-h light (0700-1900) and dark (1900-0700) cycle. Animals had free access to food (Rat Laboratory Chow, Nuvilab CR-1) and water. After 1 week of acclimation, rats were assigned to either a sedentary (n = 13) or exercise group (n = 11). Exercising rats were housed individually in cages (42 × 38 × 38 cm) equipped with running wheels, each circumrevolution corresponding to 96 cm, and allowed to run at their own pace for 5 weeks. The number of exercise wheel revolutions was recorded continuously with the aid of a digital counter attached to the wheel to quantify running distance. A group of rats housed individually in standard laboratory cages comprised a sedentary group. Both sedentary and exercising rats were weighed twice weekly at 0900.

Fasting levels of serum insulin and metabolites

At the end of the training period, exercise rats were not allowed to run for 24 h and food was removed from cages of both sedentary and exercising rats at 0800. Rats were weighed and then anesthetized at 1200 with an injection of 50 mg/kg of pentobarbital sodium (Thiopentax - Cristália Chemicals Products and Pharmaceutics Ltd, Sao Paulo, Brazil). A venous sample was obtained from a cut at the tip of the tail for measurement of glucose, insulin and free fatty acid (FFA) concentration as described below.

Measurement of in vivo insulin action

Insulin sensitivity was evaluated using the insulin suppression test previously described [41,42]. Procedure started at 1200 after 4 h fast. Briefly, rats were anesthetized by an intraperitoneal injection of 50 mg/kg pentobarbital, and right internal jugular was exposed and cannulated for administration of the infusate. Rats received a continuous infusion of glucose (8 mg/kg) and insulin (2.5 mU/kg) for 180 minutes. With this technique, comparable steady state plasma insulin levels are reached in all animals during the last hour of the study. By measuring the steady state plasma glucose concentration during the third hour, it is possible to get a direct assessment of the ability of a fixed concentration of insulin to stimulate glucose uptake in two groups. Steady state plasma glucose and insulin values were calculated from tail blood samples taken at 10-minute intervals during the last 60 minutes of the infusion and expressed as glucose and insulin areas under the curve (AUC).

Tissue collection

At the end of 5 weeks of exercise training, all animals were subjected to an insulin suppression test. Subsequently, animals were euthanized for tissue collection. The fast-twitch plantaris [43] and slow-twitch soleus [44] muscle and liver tissues were excised, frozen in liquid nitrogen and stored frozen at -80°C until analyzed.

Biochemical measurements

Serum glucose, nonesterified free fatty acids (NEFAs), and insulin levels were quantified using kits from LABTEST, Diagnostica S.A., Minas Gerais, Brazil, Linco Research Immunoassay, St. Charles, MO, USA and Boehringer Mannheim, Ingelham, Germany, respectively. For some studies, serum levels of NEFAs were also measured by a kit supplied by Wako Pure Chemical Industries Ltd., Osaka, Japan.

Immunoblotting

Tissue samples were homogenized in lysis buffer containing 100 mM Tris buffer, pH 7.5, 1% SDS, 10 mM EDTA, 100 mM sodium pyrophosphate, 100 mM NaF, 10 mM sodium vanadate, using a Polytron (Brinkmann Instruments, Westbury, NY, USA). Insoluble material was removed by centrifugation (10,000 g for 40 min at 4°C). Protein concentration of tissue lysates was determined by the Bradford dye method (Bio-Rad Laboratories Inc., Hercules, CA, USA). Equal amount of protein (75 μg) was separated on 10% SDS-PAGE gels. Proteins were transferred to nitrocellulose membranes (Millipore), blocked overnight with 5% non-fat dry milk in TBS containing 0.02% Tween-20. The nitrocellulose membranes were washed with TBS containing 0.1% Tween-20 (TBS-T) and incubated for 4 h at 22°C with primary anti-PGC-1α antibody (polyclonal antibody of rabbit against amino acids 1-300 promoted mapped near the N-terminal portion of PGC-1 - Santa Cruz Biotechnology, Santa Cruz, CA). Membranes were washed with TBS-T and incubated with appropriate secondary antibody (horseradish peroxidase-conjugated anti-rabbit IgG) for 1 h at room temperature. Bands were visualized using ECL (Amersahm, Piscataway, NJ, USA). Subsequently, visualized protein bands were scanned, photographed, and analyzed by optical densitometry with Scion Image for Windows (Scion Corporation, National Institutes of Health, Bethesda, MD, USA). Gel-loading of samples was detected by re-probing membrane blots with an anti-β-actin monoclonal antibody (1:1000 dilution; Santa Cruz Biotechnology, Santa Cruz, CA). All data were expressed as an arbitrary unit per unit of total protein mass.

Statistical analysis

Data are expressed as mean ± SE. Differences between exercise and sedentary groups were determined by an unpaired Student's t-test. P values < 0.05 were considered significant.

Results

Rats housed in the exercise wheel cages demonstrated almost linear increases in running activity with advancing time reaching to maximum value around 4 weeks (Figure 1). On an average, the rats ran a mean (Mean ± SE) of 4.102 ± 0.747 km/day. Rats weighed 188.82 ± 2.77 g before the start of the exercise regimen. Weight gain over the 5-week period was similar in control and exercise groups with a final weight of 375.68 ± 5.30 g in control (sedentary) as compared with 355.85 ± 9.51 g in the rats allowed to run spontaneously (Table 1). In contrast, exercising rats consumed significantly more food as compared to sedentary controls (P < 0.001) in order to meet their increased caloric requirement.

Table 1. Mean body weight and food intake

thumbnailFigure 1. Average daily voluntary running distance for rats for each week is shown. Values are presented as mean ± SE, n = 13.

The effects of exercise training on basal plasma glucose, insulin and FFA concentrations are listed in Table 2. Mean plasma insulin concentrations were lower in the exercise-trained rats (P < 0.001) as compared to sedentary controls. Likewise, exercise also attenuated the circulating levels of FFA (P < 0.006 vs control). In contrast, exercise-trained rats were able to maintain glucose levels equal to that of control rats (Table 2).

Table 2. Mean basal plasma glucose, free fatty acids (FFA) and insulin concentrations

Steady state plasma glucose (SSPG) and insulin (SSPI) concentrations of the two groups are shown in Figures 2 and 3. Mean steady state plasma glucose concentrations were not significantly different in sedentary control rats as compared to exercise-trained animals (Figure 2). Similarly, steady state plasma insulin concentrations were also comparable among the two groups (Figure 3). Since SSPG levels were not changed in response to exercise, it is clear that insulin-stimulated glucose uptake in insulin-sensitive normal rats was not further impacted by exercise training.

thumbnailFigure 2. Steady state plasma glucose (SSPG) concentrations in control sedentary and 5-week exercise-trained rats. Values are mean ± SE. n = 12-13 rats/group.

thumbnailFigure 3. Steady state plasma insulin (SSPI) concentrations in control sedentary and 5-week exercise-trained rats. Values are mean ± SE with n = 12-13 rats/group.

The effects of exercise training on the PGC-1α protein expression in soleus and plantaris skeletal muscles and liver as measured by Western blotting are shown in Figures 4, 5, 6. Equal loading of protein was confirmed by probing the membrane blots with an anti-actin monoclonal antibody (data not shown). Plantaris PGC-1α protein expression increased significantly from a 1.11 ± 0.12 in the sedentary rats to 1.74 ± 0.09 in exercising rats (P < 0.001) (Figure 4). However, exercise had no effect on PGC-1α protein content in either soleus muscle or liver tissue (Figures 5 and 6). These results indicate that exercise training selectively up regulates the PGC-1α protein expression in the high-oxidative fast skeletal muscle type such as plantaris muscle.

thumbnailFigure 4. Total PGC-1α protein content in plantaris muscle assessed by Western blotting in sedentary control and exercised rats. Values are mean ± SE with n = 8 rats/group. *P < 0.001 vs sedentary control.

thumbnailFigure 5. Total PGC-1α protein content in soleus muscle assessed by Western blotting in sedentary control and exercised rats. Values are mean ± SE with n = 8 rats/group.

thumbnailFigure 6. Total PGC-1α protein content in liver tissue assessed by Western blotting in sedentary control and exercised rats. Values are mean ± SE with n = 8 rats/group.

Discussion

As eluded above, PGC-1α has now emerged as a master regulator of several major metabolic pathways, including adaptive thermogenesis, glucose and fatty acid metabolism, oxidative phosphorylation, mitochondrial biogenesis, fiber type switching in skeletal muscle, and heart development [21-26]. Numerous studies also indicate that PGC-1α is a key factor involved in the regulation of insulin sensitivity [30-32,35,40] and adaptive responses to regular endurance exercise, leading to enhanced oxidative capacity of the skeletal muscle, and consequently, increased capacity for both lipid and carbohydrate utilization [36,38,39,45]. However, less is known about the potential beneficial actions of PGC-1α as a mediator of exercise-induced improvement in hepatic insulin sensitivity and how exercise impacts PGC-1α expression in the liver. Thus, the current study was initiated with an overall goal to assess the relative effects of exercise on the PGC-1α protein expression in two representatives of slow oxidative (soleus) and high-oxidative fast (plantaris) muscle types as well as in the liver and its relevance to whole body insulin sensitivity and circulating insulin and fatty acid levels. The rationale for the present study was based on our previous findings that exercise training enhances insulin sensitivity in rats and that this effect is accompanied by a reduction in circulating insulin concentration [41,46,47]. This phenomenon has been observed in normal rats [41,46,47] as well as rats fed diets enriched with glucose, fructose or sucrose [48]. The results of the current experiments not only confirm our previous observations that exercise training attenuates the plasma levels of insulin, but also lead to a significant reduction in the circulating levels of free fatty acids. More importantly, in the present study, we have demonstrated that exercise training selectively upregulates the PGC-1α expression in high-oxidative fast plantaris muscle, but have no effect on its expression in either slow oxidative soleus muscle or the liver.

It is clear from the data presented that plasma FFA levels were lower in exercise trained chow fed normal rats. However, we cannot tell if lower FFA levels noted in exercise trained rats were due to increased fatty acid oxidation by liver and/or skeletal muscle or simply the negative impact of running on the hormone-sensitive lipase (HSL) and adipose triacylglycerol lipase (ATGL), the two key enzymes involved in lipid hydrolysis and release of FFA from adipose tissue depots. The latter possibility is unlikely given that optimal functioning of both HSL and ATGL is necessary in maintaining adequate supply of FFA to sustain whole body substrate metabolism in response to exercise [49,50]. A more likely possibility that needs to be considered is that exercise training may lower protein expression of liver MTP, a molecule that is essential for VLDL assembly and secretion [51], and in turn causes increased channeling of FFA for their disposal through oxidation. Indeed, it has been shown that exercise training reduces VLDL synthesis and/or secretion at least in high-fat fed rats most likely through modulation of MTP [52]. Whether or not exercise-induced negative regulation of MTP-VLDL ultimately turns out to be responsible for the attenuation of dyslipidemia will depend on the results of future studies, but the observed reduction in circulating FFA levels supports the view that this possibility is worthy of continued consideration.

Exercise is known to cause an acute and transient increase in skeletal muscle PGC-1α gene expression [36,37,53,54]. Conversely, cessation of physical activity reduces the skeletal muscle PGC-1α mRNA expression [54]. It is suggested that exercise-increased levels of skeletal muscle PGC-1α leads to enhanced mitochondrial electron transport activities that enables cells to meet rising energy demand. We show here that spontaneous wheel running up regulates PGC-1α protein expression only in plantaris muscle, but not in soleus muscle. These results are in agreement with a previous study showing that voluntary wheel running of female ICR mice was associated with a selective increase in PGC-1α protein expression in plantaris muscle [55]. However, we cannot tell if the enhanced PGC-1α protein expression in plantaris muscle noted in the running rats was due to the effect of exercise training or simply the reflection of plantaris muscle hypertrophy [56]. Moreover, it is also unclear whether steady state increases in PGC-1α expression results from increased de novo synthesis, decreased degradation or both. Clearly, further studies will be necessary to investigate these possibilities.

The observation that exercise selectively up regulates the expression of PGC-1α only in the plantaris muscle points to a potential dissociation between exercise-mediated modulation of PGC-1α and improvements in skeletal muscle oxidative metabolism. Most of the previous studies have shown a positive correlation between exercise-induced changes in total skeletal PGC-1α mRNA and mitochondrial electron transport activities [36,37,53,54,57,58]. Our results raise the possibility that contrary to the previous findings, PGC-1α may not function as a global regulator of oxidative metabolism in response to exercise. Instead, we suggest that exercise-mediated improvement in skeletal muscle oxidative metabolism may involve improved PGC-1α action in specific muscle types (e.g., oxidative muscle such as plantaris muscle) or exercise-induced recruitment other biologically active compounds leading to increased functional efficacy of PGC-1α [59-65]. In addition, exercise-induced potential alterations in acetylation, phosphorylation, and/or methylation status of PGC-1α could also positively impact its function (65). Furthermore, since we have used 5 weeks of voluntary wheel running exercise regimen, there remains the possibility that we may have missed any potential transient increases in PGC-1α in soleus muscle studied here. Indeed, exercise is known to cause an acute and transient increase in PGC-1α gene expression in various skeletal muscle types [36,37,53,54,66] The follow-up studies are underway to assess the impact of short- and long-term exercise training on the expression of PGC-1α not only in these two muscle types, but also in a variety of other skeletal muscle types with differing fiber composition [67]. Also, experiments are in progress to determine effects of short-term and long-term exercise treatment regimen on the acetylation, phosphorylation, and/or methylation status of PGC-1α in specific skeletal muscle types as well as in liver.

Previous studies have shown that expression in the liver is robustly induced in response to acute food deprivation, insulin resistance or diabetes [25-28], but reduced in obesity [29]. Both loss-of-function and gain-of-function studies have shown that PGC-1α over expression results in hepatic insulin resistance, while PGC-1α deficiency is accompanied by alterations in hepatic energy and lipid metabolism, lipid accumulation (steatosis), insulin signaling and diminished hepatic gluconeogenesis [33-35]. These observations have led to a general thinking that hepatic PGC-1α may function as a negative modulator of insulin sensitivity, and lipid and glucose metabolism. Despite our expectations that exercise-mediated improvement in hepatic oxidative metabolism [68-70] should accompany a significant decline in PGC-1α expression, we found no change in its expression at the end of 5-weeks of exercise training of rats. It remains possible that at some point beyond 5-weeks of training, PGC-1α expression may be significantly altered or that exercise may indirectly influence PGC-1α through modulation of SIRT1 which serves as a regulator of PPARα-PGC-1α directed gene expression in liver [65]. Likewise, it is possible that we may have missed a transient change (decrease) in PGC-1α expression during the early phase of the exercise treatment regimen. Moreover, we tested the effect of exercise only in male Wistar rats, in which animals were subjected to voluntary wheel running starting at 5 weeks of age. Thus, our findings do not preclude the possibility that other important factors such as strain, sex, and age at the start of the exercise regimen may render animals more responsive to exercise-induced changes in PGC-1α expression in the liver.

In conclusion, results of the present study indicate that 5 weeks of voluntary wheel training exercise results in a significant reduction in circulating levels of insulin and FFA. Western blot analysis indicated that exercise selectively up regulated the PGC-1α protein expression, a major mediator of exercise-induced improvements in skeletal muscle oxidative metabolism and insulin sensitivity, in the high-oxidative plantaris muscle. In contrast, exercise training had no effect on the PGC-1a expression in either the slow-oxidative soleus muscle or liver. Based on these findings, we conclude that PGC-1α plays a minor role in exercise-mediated improvements in insulin resistance (sensitivity) and lowering of circulating FFA levels.

List of abbreviations used

SSPG: steady state plasma glucose; SSPI: steady state plasma insulin; AUC: area under the curve; FFA: free fatty acid; PGC-1α: peroxisome proliferator-activated receptor (PPAR)-γ coactivator.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

RM, RF, MS and DR carried out various aspects of the experiments summarized in this manuscript. RS conceived of the study and BW together with RS participated in the design and coordinated the performance of the experiments. SA provided technical advice on this project and RS and SA drafted the manuscript. All the authors read and approved the final manuscript.

Acknowledgements

This work was supported by a grant from Foundation for Research Support of Sao Paulo State, Brazil (FAPESP n° 06/54990-8; 07/56602-8) (RS) and Office of Research and Development, Medical Service, Department of Veterans Affairs (SA), and grants from the National Institutes of Health (HL033881 and HL092473) (SA).

References

  1. Reaven GM: Pathophysiology of insulin resistance in human disease.

    Physiol Rev 1995, 75:473-486. PubMed Abstract | Publisher Full Text OpenURL

  2. DeFronzo RA: Pathogenesis of type 2 diabetes mellitus.

    Med Clin North Am 2004, 88:787-835. PubMed Abstract | Publisher Full Text OpenURL

  3. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease.

    Diabetes 1988, 37:1595-607. PubMed Abstract | Publisher Full Text OpenURL

  4. Azhar S, Kelley G: PPARα: its role in the human metabolic syndrome.

    Future Lipidol 2007, 2:31-53. Publisher Full Text OpenURL

  5. Grundy SM: Metabolic syndrome.

    Arterioscler Thromb Vasc Biol 2008, 28:629-636. PubMed Abstract | Publisher Full Text OpenURL

  6. Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH: The metabolic syndrome.

    Endocr Rev 2008, 29:777-8222. PubMed Abstract | Publisher Full Text OpenURL

  7. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic.

    Nature 2001, 414:782-787. PubMed Abstract | Publisher Full Text OpenURL

  8. Unger RH: Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome.

    Endocrinology 2003, 144:5159-5165. PubMed Abstract | Publisher Full Text OpenURL

  9. Ello-Martin JA, Ledikwe JH, Rolls BJ: The influence of food portion size and energy density on energy intake.

    Am J Clin Nutr 2005, 82:236S-241S. PubMed Abstract | Publisher Full Text OpenURL

  10. Fabricatore AN, Wadden TA: Obesity.

    Annu Rev Clin Psychol 2006, 2:357-377. PubMed Abstract | Publisher Full Text OpenURL

  11. Handschin C, Spiegelman BM: The role of exercise and PGC1α in inflammation and chronic disease.

    Nature 2008, 454:463-469. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  12. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, Sacks F, Steffen LM, Wylie-Rosett J: Dietary sugars intake and cardiovascular health: A scientific statement from the American Heart Association.

    Circulation 2009, 120:1011-1020. PubMed Abstract | Publisher Full Text OpenURL

  13. Lewis GF, Carpentier A, Adeli K, Giacca A: Disordered fat storage and mobilization in the pathogensis of insulin resistance and type 2 diabetes.

    Endocr Rev 2002, 23:201-229. PubMed Abstract | Publisher Full Text OpenURL

  14. Savage DB, Petersen KF, Shulman GI: Disordered lipid metabolism and the pathogenesis of insulin resistance.

    Physiol Rev 2007, 87:507-520. PubMed Abstract | Publisher Full Text OpenURL

  15. Lara-Castro C, Garvey WT: Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome.

    Endocrinol Metab Clin N Am 2008, 37:841-856. Publisher Full Text OpenURL

  16. Stefan N, Kantartzis K, Häring H-U: Causes and metabolic consequences of fatty liver.

    Endocr Rev 2008, 29:939-960. PubMed Abstract | Publisher Full Text OpenURL

  17. Consitt LA, Bell JA, Houmard JA: Intramuscular lipid metabolism, insulin action, and obesity.

    IUBMB Life 2009, 61:47-55. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  18. Katsanos CS: Lipid-induced insulin resistance in the liver: role of exercise.

    Sports Med 2004, 34:955-965. PubMed Abstract | Publisher Full Text OpenURL

  19. Bonen A, Dohm GL, van Loon LJ: Lipid metabolism, exercise and insulin action.

    Essays Biochem 2006, 42:47-59. PubMed Abstract | Publisher Full Text OpenURL

  20. Turcotte LP, Fisher JS: Skeletal muscle insulin resistance: roles of fatty aid metabolism and exercise.

    Phy Ther 2008, 88:1279-1296. OpenURL

  21. Lin J, Handschin C, Spiegelman BM: Metabolic control through the PGC-1 family of transcription coactivators.

    Cell Metab 2005, 1:361-622. PubMed Abstract | Publisher Full Text OpenURL

  22. Finck BN, Kelley DP: PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.

    J Clin Invest 2006, 116:615-622. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  23. Puigserver P: Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.

    Int J Obes (Lond) 2005, 29(Suppl 1):S5-9. PubMed Abstract | Publisher Full Text OpenURL

  24. Liang H, Ward WF: PGC-1α: a key regulator of energy metabolism.

    Adv Physiol Educ 2006, 30:145-151. PubMed Abstract | Publisher Full Text OpenURL

  25. Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM: PGC-1β in the regulation of hepatic glucose and energy metabolism.

    J Biol Chem 2003, 278:30843-30848. PubMed Abstract | Publisher Full Text OpenURL

  26. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.

    Nature 2001, 413:131-138. PubMed Abstract | Publisher Full Text OpenURL

  27. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.

    Nature 2001, 413:179-183. PubMed Abstract | Publisher Full Text OpenURL

  28. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gozalez FJ, Spiegelman BM: Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis.

    Proc Natl Acad Sci USA 2003, 100:4012-4017. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  29. Crunkhorn S, Dearie F, Mantzoros C, Gami H, da Silva WS, Espinoza D, Faucette R, Barry K, Bianco AC, Patti ME: Peroxisomal proliferator activator receptor γ coactivator-1 expression is reduced in obesity: potential pathogenic role of fatty acids and p38 mitogen-activated protein kinase activation.

    J Biol Chem 2007, 282:15439-15450. PubMed Abstract | Publisher Full Text OpenURL

  30. Liang H, Balas B, tantiwong P, Dube J, Goodpaster BH, O'Doherty RM, DeFronzo RA, Richardson A, Musi N, Ward WF: Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity.

    Am J Physiol Endocrinol Metab 2009, 296:E945-E954. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  31. Choi CS, Befroy DE, Codella R, Kim S, Reznick RM, Hwang Y-J, Liu Z-X, Lee H-Y, Distefano A, Samuel VT, Zhang D, Cline GW, Handschin C, Lin J, Petersen KF, Spiegelman BM, Schulman GI: Paradoxical effects of increased expression of PGC-1α on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.

    Proc Natl Acad Sci USA 2008, 105:19926-19931. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  32. Pagel-Langenickel I, Bao J, Joseph JJ, Schwartz DR, Mantell BS, Xu X, Raghavachari N, Sack MN: PGC-1α integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle.

    J Biol Chem 2008, 283:22464-22472. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  33. Leone TC, Lehman JJ, Flinck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelley DP: PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis.

    PloS Biol 2005, 3:e101. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  34. Burgess SC, Leone TC, Wende AR, Croce MA, Chen Z, Sherry AD, Malloy CR, Finck BN: Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α)-deficient mice.

    J Biol Chem 2006, 281:1900-19008. OpenURL

  35. Estall JL, Kahn M, Cooper MP, Fisher FM, Wu MK, Laznik D, Qu L, Cohen DE, Shulman GI, Spiegelman BM: Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-γ coactivator-1α expression.

    Diabetes 2009, 58:1499-1508. PubMed Abstract | Publisher Full Text OpenURL

  36. Baar K, Wende AR, Jones TE, Marison M, Notle LA, Chen M, Kelley DP, Holloszy JO: Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1.

    FASEB J 2002, 16:1879-1886. PubMed Abstract | Publisher Full Text OpenURL

  37. Miura S, Kawanaka K, Kai Y, Tamura M, Goto M, Shiuchi T, Minokoshi Y, Ezaki O: An increase in murine skeletal muscle peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated by β-adnergic receptor activation.

    Endocrinology 2007, 148:3441-3448. PubMed Abstract | Publisher Full Text OpenURL

  38. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han D-H, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, Holloszy JO, Kelly DP: A role for the transcriptional coactivator PGC-1α in muscle refueling.

    J Biol Chem 2007, 282:36642-36651. PubMed Abstract | Publisher Full Text OpenURL

  39. Calvo JA, Daniels TG, Wang X, Paul A, Lin J, Spiegelman BM, Stevenson SC, Rangwala SM: Muscle-specific expression of PPARγ coactivator-1α improves exercise performance and increases peak oxygen uptake.

    J Appl Physiol 2008, 104:1304-1312. PubMed Abstract | Publisher Full Text OpenURL

  40. Bonen A: PGC-1α-induced improvements in skeletal muscle metabolism and insulin sensitivity.

    Appl Physiol Nutr Metab 2009, 34:307-314. PubMed Abstract | Publisher Full Text OpenURL

  41. Santos RF, Azhar S, Mondon C, Reaven E: Prevention of insulin resistance by environmental manipulation as young rats mature.

    Horm Metab Res 1989, 21:55-58. PubMed Abstract | Publisher Full Text OpenURL

  42. Rodnick KJ, Mondon CE, Haskell WL, Azhar S, Reaven GM: Differences in insulin-stimulated glucose uptake and enzyme activity in running rats.

    J Appl Physiol 1990, 68:513-519. PubMed Abstract | Publisher Full Text OpenURL

  43. Henriksen EJ, Halseth AE: Adaptive responses of GLUT-4 and citrate synthase in fast-twitch muscle of voluntary running rats.

    Am J Physiol Regul Integr Comp Physiol 1995, 268:R130-R134. OpenURL

  44. Tupling AR, Asahi M, MacLennan DH: Sarcolipin overexpression in rat slow twitch muscle inhibits sarcoplasmic reticulum Ca2+ uptake and impairs contractile function.

    J Biol Chem 2002, 277:44746-44746. Publisher Full Text OpenURL

  45. Pilegaard H, Richter EA: PGC-1α: important for exercise performance?

    J Appl Physiol 2008, 104:1264-1265. PubMed Abstract | Publisher Full Text OpenURL

  46. Mondon CE, Dolkas CB, Reaven GM: Site of enhanced insulin sensitivity in exercise trained rats at rest.

    Am J Physiol 1980, 239:E169-E177. PubMed Abstract | Publisher Full Text OpenURL

  47. Santos RF, Mondon CE, Reaven GM, Azhar S: Effects of exercise training on the relationship between insulin binding and insulin-stimulated tyrosine kinase activity in rat skeletal muscle.

    Metabolsim 1989, 38:376-386. OpenURL

  48. Zavaroni I, Chen Y-DI, Mondon CE, Reaven GM: Ability of exercise to inhibit carbohydrate-induced hypertriglyceridemia in rats.

    Metabolism 1981, 30:476-480. PubMed Abstract | Publisher Full Text OpenURL

  49. Fernandez C, Hansson O, Nevesten P, Holm C, Klint C: Hormone-sensitive lipase is necessary for normal mobilization of lipid during submaximal exercise.

    Am J Physiol Endocrinol Metab 2008, 295:E179-E186. PubMed Abstract | Publisher Full Text OpenURL

  50. Huijsman E, par C, Economou C, Poel C, Lynch GS, Schoiswohl G, Haemmerle G, Zechner R, Watt MJ: Adipose triacylglycerol lipase alters whole body energy metabolism and impairs exercise performance in mice.

    Am J Physiol Endocrinol Metab 2009, 297:E505-513. PubMed Abstract | Publisher Full Text OpenURL

  51. Hussain MM, Shi J, Dreizen P: Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly.

    J Lipid Res 2003, 44:22-32. PubMed Abstract | Publisher Full Text OpenURL

  52. Chapados NA, Seelaender M, Levy E, Lavoie J-M: Effects of exercise training on hepatic microsomal triglyceride transfer protein content in rats.

    Horm Metab Res 2009, 41:287-293. PubMed Abstract | Publisher Full Text OpenURL

  53. Pilegaard H, Staltin B, Neufer PD: Exercise induces transient transcriptional activation of the PGC-1 alpha gene in human skeletal muscle.

    J Physiol 2003, 546:851-858. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  54. Laye MJ, Rector RS, Borengasser SJ, Naples SP, Uptergrove GM, Ibdah JA, Booth FW, Thyfault JP: Ceassation of daily wheel running differentially alters fat oxidation capacity in liver, muscle, and adipose tissue.

    J Appl Physiol 2009, 106:161-168. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  55. Ikeda S, Kawamoto H, Kasaoka K, Hitomi Y, Kizaki T, Sankai Y, Ohno H, Haga S, Takemasa T: Muscle type-specific response of PGC-1α and oxidative enzymes during voluntary wheel running in mouse skeletal muscle.

    Acta Physiol 2006, 188:217-223. Publisher Full Text OpenURL

  56. Ishihara A, Roy RR, Ohira Y, Ibata Y, Edgerton R: Hypertrophy of rat plantaris muscle fibers after voluntary running with increased loads.

    J Appl Physiol 1998, 84:2183-2189. PubMed Abstract | Publisher Full Text OpenURL

  57. Russell AP: PGC-1alpha and exercise: important partners in combating insulin resistance.

    Curr Diabetes Rev 2005, 1:175-181. PubMed Abstract | Publisher Full Text OpenURL

  58. Benton CR, Wright DC, Bonen A: PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions.

    Appl Physiol Nutr Metab 2008, 33:843-862. PubMed Abstract | Publisher Full Text OpenURL

  59. Winder WW, Taylor EB, Thomson DM: Role of AMP-activated protein kinase in the molecular adaptation to endurance exercise.

    Med Sci Sports Exerc 2006, 38:1945-1949. PubMed Abstract | Publisher Full Text OpenURL

  60. Bowtell JL, Marwood S, Bruce M, Constantin-Teodosiu D, Greenhaff PL: Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle.

    Sports Med 2007, 37:1071-1088. PubMed Abstract | Publisher Full Text OpenURL

  61. Ghanassia E, Brun JF, Mercier J, Raynaud E: Oxidative mechanism at rest and during exercise.

    Clin Chim Acta 2007, 383:1-20. PubMed Abstract | Publisher Full Text OpenURL

  62. Gibala M: Molecular responses to high-intensity interval exercise.

    Appl Physiol Nutr Metab 2009, 34:428-432. PubMed Abstract | Publisher Full Text OpenURL

  63. Handschin M, Spiegelman BM: Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and Metabolism.

    Endocr Rev 2006, 27:728-735. PubMed Abstract | Publisher Full Text OpenURL

  64. Lin JD: Minireview: The PGC-1 coactivator networks: chromatin-remodeling and mitochondrial energy metabolism.

    Mol Endocrinol 2009, 23:2-10. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  65. Sudgen MC, Caton PW, Holness MJ: PPAR control: it's SIRTainly as easy as PGC.

    J Endocrinol 2010, 204:93-104. PubMed Abstract | Publisher Full Text OpenURL

  66. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS, Yan Z: Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway.

    J Biol Chem 2005, 280:19587-19593. PubMed Abstract | Publisher Full Text OpenURL

  67. Azhar S, Butte JC, Santos RF, Mondon CE, Reaven GM: Characterization of insulin receptor kinase activity and autophosphorylation in different skeletal muscle types.

    Am J Physiol 1991, 260:E1-E7.

    (Endocrinol Metab 23)

    PubMed Abstract | Publisher Full Text OpenURL

  68. Bobyleva-Guarriero V, Lardy HA: The role of malate in exercise-induced enhancement of mitochondrial respiration.

    Arch Biochem Biophys 1986, 245:470-476. PubMed Abstract | Publisher Full Text OpenURL

  69. Tate CA, Scherer NM, Stewart G: Adrenergic influence of hormonal and hepatic metabolic response to exercise.

    Am J Physiol 1986, 250:R1060-1064. PubMed Abstract | Publisher Full Text OpenURL

  70. Wasserman DH, Cherrington AD: Hepatic fuel metabolism during muscular work: role and regulation.

    Am J Physiol 1991, 260:E811-1824. PubMed Abstract | Publisher Full Text OpenURL